08:38 ETWorld's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceuticalprnewswire·Apr 28 at 12:39 PM浙江博锐生物制药股份有限公司科兴生物制药股份有限公司
UBS lowers the target price for SINO BIOPHARM to 11 yuan, rating it as "Buy"AASTOCKS·Mar 30 at 04:28 AM516930+0.20%159892-0.13%
